SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-338814
Filing Date
2017-11-09
Accepted
2017-11-09 16:26:00
Documents
3
Period of Report
2017-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d489783d8k.htm 8-K 14988
2 EX-99.1 d489783dex991.htm EX-99.1 45889
3 GRAPHIC g489783q.jpg GRAPHIC 7414
  Complete submission text file 0001193125-17-338814.txt   72347
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38085 | Film No.: 171191217
SIC: 2834 Pharmaceutical Preparations